HWG Holdings’s Gilead Sciences GILD Stock Holding History

HWG Holdings’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-916	Closed	-$103K	–	81
2025 Q1	$103K	Buy	+916	New	+$94.5K	0.05%	48
2024 Q3	–	Sell	-916	Closed	-$62.8K	–	76
2024 Q2	$62.8K	Buy	+916	New	+$61.1K	0.02%	53
2023 Q4	$74.2K	Hold	916	–	–	0.03%	58
2023 Q3	$68.6K	Hold	916	–	–	0.04%	59
2023 Q2	$70.6K	Hold	916	–	–	0.03%	68
2023 Q1	$76K	Hold	916	–	–	0.04%	56
2022 Q4	$79K	Buy	+916	New	+$72.5K	0.05%	58
2020 Q4	–	Sell	-916	Closed	-$58K	–	109
2020 Q3	$58K	Hold	916	–	–	0.05%	75
2020 Q2	$70K	Buy	+916	New	+$70.2K	0.06%	75
2014 Q4	–	Sell	-87,457	Closed	-$9.31M	–	37
2014 Q3	$9.31M	Buy	87,457 +71,738	+456%	+$7.02M	7.47%	3
2014 Q2	$1.3M	Buy	+15,719	New	+$1.22M	0.99%	33

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HWG Holdings's GILD Position: Q2 2025 in Review

HWG Holdings sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 916 shares — an estimated $103K sold.

HWG Holdings first reported a position in GILD in Q2 2014 and held it in 11 quarters. The position peaked at $9.31M in Q3 2014. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

HWG Holdings reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
HWG Holdings sold 916 Gilead Sciences shares in Q2 2025, an estimated $103K.
HWG Holdings first reported a position in Gilead Sciences in Q2 2014 and held it in 11 quarters.
HWG Holdings's Gilead Sciences position peaked at $9.31M in Q3 2014.
2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on HWG Holdings's 13F filing for Q2 2025, filed 10 Jul 2025.